There are actually two ways in which a manufacturer of a medical device, including infamous ones like certain types of hip implants and vaginal mesh, can get permission from the Food and Drug Administration to market it to the public.
This blog has on several previous occasions reported medical product liability issues with the blood pressure drug valsartan. Several recalls over the past several months have called the safety of the drug in to question, as quantities manufactured overseas have been discovered to include impurities that could cause cancer.
A few years back, the drug manufacturer Pfizer promoted its new product, Xeljanz, as a medicine that could treat a number of ailments that can afflict residents of Northern Georgia.
For a number of years, doctors have used transvaginal mesh products to treat a condition called stress urinary incontinence. This is a medical condition that many women in Northern Georgia and other parts of the country experience in which they will involuntarily urinate while engaging in physical activity or even after a hard sneeze or cough.
Two major drug manufacturers agreed recently to pay $775 million to settle over 25,000 lawsuits filed with respect to the drug Xarelto. As previous posts here have discussed, the drug was supposed to prevent blood clotting. However, it wound up carrying with it the risk of severe and potentially fatal side effects, including significant and uncontrollable bleeding.
There have been several recalls of blood pressure medications following the discovery of chemicals within them that are known carcinogens, that is, chemicals which increase the risk of cancer. Medicinal drugs are, albeit on a much grander scale, made in the same way that one may have performed chemical experiments in high school science class. In other words, the active ingredient in a drug is the result of a chemical reaction in which chemists and their assistants use existing molecules to create helpful medicine.
The last few weeks have seen a rash of additional recalls of the blood pressure medicine Valsartan, with three separate recalls happening in one week. Lest one think that multiple recalls in a week are just an anomaly, there were two others in the week before or after.
Republicans and Democrats on a committee of the House of Representatives are asking the federal Food and Drug Administration, or FDA, for a report on the status of certain blood pressure medicines that are commonly manufactured in foreign plants.
Life is stressful for many Rome, Georgia, residents. For that and for many other reasons, they may develop depression. Other people in the area suffer with bipolar disorder or schizophrenia, both of which are serious mental health conditions that arise for genetic and other reasons.
There are many people in Georgia who suffer from high blood sugar to the point where they need to take medication for this condition.